0
Skip to Content
Maxwell Biosciences
Cosmetics
HealthSpan
Pipeline
Our Technology
Epstein-Barr
News
Team
Careers
Investors
Maxwell Biosciences
Cosmetics
HealthSpan
Pipeline
Our Technology
Epstein-Barr
News
Team
Careers
Investors
Folder: Microbiome
Back
Cosmetics
HealthSpan
Pipeline
Folder: Technology
Back
Our Technology
Epstein-Barr
News
Team
Careers
Investors

Maxwell Biosciences, Inc.

Austin, Texas
United States of America

Company

HealthSpan
Pipeline
Technology
Team
Science
News
Careers
Investors

News

Featured
Maxwell to Present “Peptoids: The Future of Pharmaceutical Peptides”
Maxwell to Present “Peptoids: The Future of Pharmaceutical Peptides”

Maxwell's Scotch McClure will give a presentation "Peptoids: The Future of Pharmaceutical Peptides" at the Drug Discovery Innovation Programme 2026 September 29-30 in Switzerland.

Read more →
Maxwell Biosciences’ Claromers Destroy Epstein-Barr
Maxwell Biosciences’ Claromers Destroy Epstein-Barr

Maxwell Biosciences is part of a scientific revolution that sees a different story in the data. We believe that many of the most devastating brain diseases are not just failures of aging, but the result of a failed immune conversation. The brain is a fortress, but even the strongest walls need a modern defense.

Read more →
Rethinking the Resilient Brain: The New Frontier of Immuno-Neurology
Rethinking the Resilient Brain: The New Frontier of Immuno-Neurology

Maxwell Biosciences is part of a scientific revolution that sees a different story in the data. We believe that many of the most devastating brain diseases are not just failures of aging, but the result of a failed immune conversation. The brain is a fortress, but even the strongest walls need a modern defense.

Read more →
Fighting Neonatal Sepsis in India
Fighting Neonatal Sepsis in India

Neonatal sepsis is a severe blood infection in newborns and is the leading cause of infant mortality in India. Over 50% of these cases are now multi-drug resistant (MDR). Traditional antibiotics, once our strongest defense, are increasingly failing against "superbugs," leaving doctors and parents with few options.

Read more →
Maxwell Biosciences Subsidiary Havih Announces Partnership with the Government of Andhra Pradesh
Maxwell Biosciences Subsidiary Havih Announces Partnership with the Government of Andhra Pradesh

Havih Envirosciences, a subsidiary of Maxwell Biosciences, announces a strategic partnership with the Government of Andhra Pradesh to establish advanced pharmaceutical research and production capabilities, supporting branded innovation, India-based IP creation and high-skill job growth.

Read more →

Science

Featured
Screen-Shot-2020-05-05-at-8.26.06-AM.png
Maxwell Peptoids Active Against Herpes Simplex 1 (HSV-1)
Read more →
peptoids.gif
Next Generation Virucides – Peptoids
Read more →

Copyright © 2016 - 2026. Maxwell Biosciences and CLAROMER are registered trademarks of Maxwell Biosciences, Inc. All rights reserved.

Unless otherwise stated, the information on this website has not been evaluated by the Food & Drug Administration. As a research organization, we do not diagnose, treat, cure or prevent any illness or disease. Information is shared for educational purposes only. You must consult your doctor before acting on any content on this website, especially if you are pregnant, nursing, taking medication, or have a medical condition. Compounds in our clinical development programs are tested in animals in accordance with federal preclinical requirements. Compounds developed for cosmetics and personal care items are not tested on animals.